ALBPS — Biophytis SA Income Statement
0.000.00%
Last trade - 00:00- €1.31m
- €8.57m
Annual income statement for Biophytis SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | — | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 13.9 | 26.8 | 23.3 | 14.3 | 8.5 |
| Operating Profit | -13.9 | -26.8 | -23.3 | -14.3 | -8.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -25.5 | -31.2 | -24.2 | -17 | -10.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -25.5 | -31.2 | -24.2 | -17 | -10.4 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -25.5 | -31.2 | -24.2 | -17 | -10.4 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -25.5 | -31.2 | -24.2 | -17 | -10.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -170 | -105 | -55.4 | -12.5 | -2 |
| Dividends per Share |